Michael D. Clayman is CEO & President at Flexion Therapeutics Inc (FLXN). They have made 16 open-market trades across 1 company since 2016, most recently 2021-11-19.
CIK 0001597407
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
16 open-market purchases totalling $1.3M since 2016, never a sale. Across 16 scored buys the stock is up 26.6% at ninety days, and 21.6 points ahead of the S&P over the same stretch.
16 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| FLXN | 334,981 | $8.1M |
Shares reported on the most recent Form 4, priced at the 2021-07-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 69% | 75% | 69% |
| Avg Move | +19.9% | +14.1% | +26.6% |
| Alpha | +18.8% | +12.8% | +21.6% |
| Scored | 16 | 16 | 16 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FLXN | BUY | 2020-05-26 | 2020-05-27 | $9.75 | $100K | +19.7% | +16.8% | +7.2% |
| FLXN | BUY | 2019-08-08 | 2019-08-08 | $10.85 | $25K | +0.3% | +24.9% | +56.6% |
| FLXN | BUY | 2019-05-10 | 2019-05-13 | $12.48 | $100K | +2.5% | -9.9% | -7.0% |
| FLXN | BUY | 2019-03-12 | 2019-03-13 | $12.36 | $100K | -8.1% | -16.3% | -11.6% |
| FLXN | SELL · 10b5-1 | 2019-01-03 | 2019-01-04 | $12.36 | $41K | +1.4% | +6.5% | -5.4% |
| FLXN | BUY | 2018-11-09 | 2018-11-13 | $17.10 | $86K | -3.7% | -17.7% | -17.4% |
| FLXN | BUY | 2018-08-09 | 2018-08-10 | $22.33 | $447K | -6.6% | -6.3% | -26.6% |
| FLXN | BUY | 2017-11-08 | 2017-11-09 | $23.60 | $118K | -1.1% | +5.2% | -2.2% |
| FLXN | BUY | 2017-06-05 | 2017-06-06 | $17.23 | $86K | -1.4% | +26.1% | +33.8% |
| FLXN | BUY | 2016-11-23 | 2016-11-23 | $18.41 | $31K | +1.7% | +11.6% | +5.9% |
| FLXN | BUY | 2016-11-22 | 2016-11-23 | $17.95 | $30K | +1.7% | +11.6% | +5.9% |
| FLXN | BUY | 2016-11-21 | 2016-11-22 | $17.90 | $30K | +2.3% | +3.7% | +9.8% |
| FLXN | BUY | 2016-05-20 | 2016-05-23 | $10.41 | $21K | +50.0% | +28.6% | +67.4% |
| FLXN | BUY | 2016-05-19 | 2016-05-20 | $9.65 | $19K | +62.5% | +33.7% | +69.1% |
| FLXN | BUY | 2016-05-18 | 2016-05-19 | $10.23 | $20K | +71.9% | +43.2% | +81.9% |
| FLXN | BUY | 2016-05-17 | 2016-05-18 | $9.73 | $19K | +70.5% | +29.8% | +73.3% |
| FLXN | BUY | 2016-05-16 | 2016-05-17 | $9.51 | $19K | +56.4% | +40.1% | +79.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.